Key facts
- This page summarizes Huma Qamar's Form 3 filing for Ocugen, Inc. (OCGN).
- 0 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 20 Mar 2024, 18:08.
Huma Qamar - 18 Mar 2024 Form 3 Insider Report for Ocugen, Inc. (OCGN)
- Reporting relationship
- Chief Medical Officer
- Issuer ticker
- OCGN
- Reported as of
- 18 Mar 2024
- Net transaction value
- $0
- SEC form
- 3
- Accepted by SEC
- 20 Mar 2024, 18:08:21 UTC
- Next SEC filing
- 17 Apr 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Huma Qamar
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Huma Qamar filed Form 3 for Ocugen, Inc. (OCGN) on 20 Mar 2024.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
OCGN
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 1,643
- Date
- 18 Mar 2024
- Ownership
- Direct
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
SEC remarks
Exhibit List: Exhibit 24.1 - Power of Attorney